Skip to main content

Table 1 Demographics and baseline characteristics

From: Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial

Mean (SD)

LMWF-5A (n = 144)

Saline (n = 24)

Historical saline (n = 223)

Female sex, % (n)

52.8 (76)

50.0 (12)

51.6 (113)

Age, years

62.7 (9.6)

64.0 (6.3)

63.1 (8.6)

BMI (lb/in2)

32.7 (6.4)

31.4 (6.3)

34.4 (7.9)

Caucasian race

77.1 (111)

66.7 (16)

88.8 (198)

Patient global assessment (PGA)

2.8 (0.8)

2.7 (0.8)

2.6 (0.8)

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

 WOMAC Pain

2.5 (0.6)

2.4 (0.4)

2.3 (0.6)

 WOMAC Stiffness

2.8 (0.7)

2.8 (0.6)

2.5 (0.7)

 WOMAC Function

2.6 (0.5)

2.5 (0.5)

2.4 (0.6)

Back to article page

Patient Safety in Surgery

ISSN: 1754-9493